Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi
Authors:
- 1 January 2008
- journal article
- case report
- Published by SAGE Publications in Tropical Doctor
- Vol. 38 (1) , 30-32
Abstract
This study shows that cabergoline (single oral-dose) is an acceptable, safe and effective drug for suppressing puerperal lactation. It could be of operational benefit not only for artificial feeding, but also for weaning in those that breast-feed within preventive mother-to-child HIV transmission programmes in resource-limited settings.Keywords
This publication has 4 references indexed in Scilit:
- Breast-feeding and Transmission of HIV-1JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Breast-Feeding and HIV-1 Transmission in Resource-Limited SettingsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Breast Milk Transmission of HIV‐1 Laboratory and Clinical StudiesAnnals of the New York Academy of Sciences, 2000
- Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.BMJ, 1991